CCL4
C-C motif chemokine 4
Also known as: Act-2, AT744.1, CCL4_HUMAN, LAG1, MIP-1-beta, SCYA4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P13236
- Gene
- CCL4
- Ensembl
- ENSG00000275302
- Chromosome
- 17
- Canonical length
- 92 aa
- Protein class
- Cancer-related genes, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a mitogen-inducible monokine and is one of the major HIV-suppressive factors produced by CD8+ T-cells. The encoded protein is secreted and has chemokinetic and inflammatory functions. [provided by RefSeq, Dec 2012]
Canonical amino-acid sequenceUniProt
92 residues, UniProt reviewed canonical sequence.
>P13236|CCL4
1 MKLCVTVLSL LMLVAAFCSP ALSAPMGSDP PTACCFSYTA RKLPRNFVVD YYETSSLCSQ
61 PAVVFQTKRS KQVCADPSES WVQEYVYDLE LNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCL4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 182 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 182 nTPM
- liver: 79 nTPM
- spleen: 78 nTPM
- urinary bladder: 52 nTPM
- lung: 44 nTPM
- gallbladder: 42 nTPM
Single-cell type
- nk-cells: 414 nCPM
- t-cells: 186 nCPM
- macrophages: 101 nCPM
- monocytes: 87 nCPM
- hofbauer cells: 85 nCPM
- neutrophils: 62 nCPM
Immune cell
- gdT-cell: 416 nTPM
- memory CD8 T-cell: 241 nTPM
- naive CD8 T-cell: 182 nTPM
- total PBMC: 139 nTPM
- eosinophil: 136 nTPM
- MAIT T-cell: 102 nTPM
Brain region
- choroid plexus: 5.3 nTPM
- cerebellum: 3.9 nTPM
- white matter: 3.8 nTPM
- medulla oblongata: 3.5 nTPM
- cerebral cortex: 3.4 nTPM
- pons: 2.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CCL4.
Disease | ImmuneIEDB
Conditions an epitope on CCL4 was assayed in.
- berylliosis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.37
- gnomAD pLI
- 0.24
- gnomAD missense Z
- -0.64
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antimicrobial humoral immune response mediated by antimicrobial peptide
- cell adhesion
- cell-cell signaling
- chemokine-mediated signaling pathway
- eosinophil chemotaxis
- establishment or maintenance of cell polarity
- host-mediated suppression of viral transcription
- immune response
- inflammatory response
- positive regulation of calcium ion transport
- positive regulation of calcium-mediated signaling
- positive regulation of cell migration
- positive regulation of natural killer cell chemotaxis
- response to toxic substance
- response to virus
- signal transduction
Molecular functions
- CCR chemokine receptor binding
- CCR1 chemokine receptor binding
- CCR5 chemokine receptor binding
- chemokine activity
- cytokine activity
- identical protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCL4 as an antibody target. Whether an autoantibody or antibody against CCL4 could matter depends on whether native CCL4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCL4 is annotated as secreted, so native CCL4 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CCL4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...